Tilaknagar Industries Q1 FY27 Results Analysis: Net Revenue Hits Record High, Margin Compression Persists

CompoundingAI Research Updated July 27, 2026 2 min read
Neutral

Tilaknagar Industries Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 1,046.03 Cr (+165.54% YoY) and PAT growth of -64.31% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 27, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 1,046.03 Cr (+165.54% YoY)
PAT (Q1)Rs. 31.59 Cr (-64.31% YoY)
EBITDA margin16.15% (-783 bps YoY)
EPS (Q1)Rs. 1.28 (-72.00% YoY)
Market capRs. 11,052.16 Cr
CMPRs. 446.70

Quarter Snapshot

Tilaknagar Industries reported its highest-ever quarterly Net Revenue of Rs.1,046 Cr, driven by the first full quarter of the Imperial Blue acquisition, with strong sequential growth of 10.2%. However, margin compression from the lower-margin IB business, elevated finance costs, and a qualified audit opinion on impairment assessment temper the results. Management's guidance for volume growth and margin expansion by FY29 remains on track, with integration costs halving sequentially.

Key Investment Insights

Key Positives

  • Net Revenue of Rs.1,046.03 Cr – highest quarterly figure in the company's history
  • Sequential Net Revenue growth of 10.2% QoQ
  • Record monthly volumes: 3.4 million cases in June 2026
  • Normalized PAT grew 29.5% QoQ to Rs.61.71 Cr
  • Finance costs declined 3.7% QoQ to Rs.66.36 Cr
  • Exceptional items halved QoQ from Rs.62.54 Cr to Rs.30.12 Cr

Risk Factors

  • EBITDA margin compressed from 23.98% to 16.15% YoY due to acquisition of lower-margin IB business
  • Cost of materials as % of Net Revenue increased from 49.13% in Q4FY26 to 52.25% due to glass bottle price increases
  • Qualified audit opinion – company failed to perform impairment assessment on one ENA plant
  • Subsidiaries reported net loss of Rs.1.84 Cr
  • High finance costs of Rs.66.36 Cr due to acquisition debt
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now